HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[3H]TCP binding sites in Alzheimer's disease.

Abstract
Quantitative autoradiography was used to determine the density and distribution of [3H]1-[1-(2-thienyl)-cyclohexyl]piperidine ([3H]TCP) binding sites in human hippocampal tissue sections from control and Alzheimer's disease patients. Some Alzheimer's cases showed no changes in binding site density while other cases showed substantial declines in the CA1 region. [3H]TCP binding in the CA1 region from Alzheimer's patients was reduced an average of 40% while the other hippocampal regions were unaffected. It is proposed that the loss of [3H]TCP sites in the hippocampal CA1 region of certain Alzheimer's cases is associated with the greater cell loss observed in cases of severe Alzheimer's disease.
AuthorsD T Monaghan, J W Geddes, D Yao, C Chung, C W Cotman
JournalNeuroscience letters (Neurosci Lett) Vol. 73 Issue 2 Pg. 197-200 (Jan 14 1987) ISSN: 0304-3940 [Print] Ireland
PMID3029638 (Publication Type: Journal Article)
Chemical References
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter
  • tenocyclidine
  • Phencyclidine
Topics
  • Alzheimer Disease (metabolism)
  • Autoradiography
  • Binding Sites
  • Hippocampus (metabolism)
  • Humans
  • Phencyclidine (analogs & derivatives, metabolism)
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: